Roche Holding AG

FDA committee backs Roche’s lymphoma treatment

3:10 a.m. March 10, 2023

- Mauro Orru

This chart offers one reason that European stocks may continue to outperform U.S. equities

8:45 a.m. Feb. 17, 2023

- Steve Goldstein

Bayer’s stock rallies after naming Roche exec as new CEO

3:52 p.m. Feb. 8, 2023

- Jaimy Lee

Roche profit misses forecasts, sees COVID-19 related sales decline ahead

3:03 a.m. Feb. 2, 2023

- Cecilia Butini

Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend

2:39 a.m. Feb. 1, 2023

- Cecilia Butini

Our Roundtable Pros Scoured the Market. Here Are 26 of Their Top Stock Picks.

9:27 a.m. Jan. 23, 2023

- Barron's Online

Kronos Bio’s stock rallies after announcing drug-discovery deal with Roche

9:23 a.m. Jan. 9, 2023

- Jaimy Lee

Inflammation after COVID may cause loss of smell, new study finds

12:12 p.m. Dec. 22, 2022

- Jaimy Lee

Roche gets full FDA approval for COVID-19 treatment

10:49 a.m. Dec. 22, 2022

- Jaimy Lee

What to know about the Alzheimer’s drug data coming out this week

3:15 p.m. Nov. 30, 2022

- Jaimy Lee

Merck & Co. Inc. stock falls Wednesday, underperforms market

6:10 p.m. Nov. 23, 2022

- MarketWatch Automation

Eli Lilly & Co. stock rises Wednesday, still underperforms market

6:06 p.m. Nov. 23, 2022

- MarketWatch Automation

Amgen Inc. stock underperforms Wednesday when compared to competitors

5:36 p.m. Nov. 23, 2022

- MarketWatch Automation

Abbott Laboratories stock rises Wednesday, outperforms market

5:33 p.m. Nov. 23, 2022

- MarketWatch Automation

Merck & Co. Inc. stock rises Tuesday, still underperforms market

6:09 p.m. Nov. 22, 2022

- MarketWatch Automation

Eli Lilly & Co. stock underperforms Tuesday when compared to competitors

6:06 p.m. Nov. 22, 2022

- MarketWatch Automation

Amgen Inc. stock underperforms Tuesday when compared to competitors

5:36 p.m. Nov. 22, 2022

- MarketWatch Automation

Abbott Laboratories stock rises Tuesday, still underperforms market

5:33 p.m. Nov. 22, 2022

- MarketWatch Automation

Eli Lilly & Co. stock falls Monday, still outperforms market

6:06 p.m. Nov. 21, 2022

- MarketWatch Automation

Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains

5:36 p.m. Nov. 21, 2022

- MarketWatch Automation

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

10:54 a.m. Jan. 22, 2018

- The Wall Street Journal Interactive Edition

Bristol-Myers Reports Higher Sales, Earnings

7:31 a.m. April 28, 2015

- The Wall Street Journal Interactive Edition

Swiss Companies Battle Strong Franc

11:52 a.m. March 2, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

4:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Roche Gets FDA Priority Review for Cancer Treatment

2:34 a.m. March 20, 2015

- The Wall Street Journal Interactive Edition

Roche Sees Profit, Sales Increasing

4:46 a.m. Jan. 28, 2015

- The Wall Street Journal Interactive Edition

Young Drive an Urban Rebound

12:50 a.m. Jan. 3, 2015

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

8:16 p.m. Dec. 29, 2014

- The Wall Street Journal Interactive Edition

Roche Wins Approval for Ebola Test

10:44 a.m. Dec. 29, 2014

- The Wall Street Journal Interactive Edition

Roche Hit by Failure of Cancer Drug Trial

12:55 p.m. Dec. 19, 2014

- The Wall Street Journal Interactive Edition

France Told To Do More for Investors

11:24 a.m. Dec. 17, 2014

- The Wall Street Journal Interactive Edition

Roche’s Genentech Seeks Approval for Skin Cancer Drug

3:12 a.m. Dec. 15, 2014

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

1:30 a.m. Dec. 15, 2014

- The Wall Street Journal Interactive Edition

Business Briefs: News Digest

8:47 p.m. Dec. 14, 2014

- The Wall Street Journal Interactive Edition

Roche Names New Genentech R&D Chief

6:53 a.m. Dec. 12, 2014

- The Wall Street Journal Interactive Edition

Merck Drug Shrank Tumors in Some Breast Cancer Patients

9:30 a.m. Dec. 10, 2014

- The Wall Street Journal Interactive Edition

Cancer’s Super-Survivors

4:58 p.m. Jan. 8, 2015

- The Wall Street Journal Interactive Edition

Bristol-Myers Drug Shows Promise for Skin-Cancer Patients

3:31 a.m. Dec. 15, 2014

- The Wall Street Journal Interactive Edition

Roche Holding AG May Submit Ebola Test For Emergency Use Approvals

2:24 p.m. Oct. 16, 2014

- The Wall Street Journal Interactive Edition

Roche Boosted by Cancer Drugs

5:26 a.m. Oct. 16, 2014

- The Wall Street Journal Interactive Edition